Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Meta Platforms
META
Adobe
ADBE
US Stock MarketDetailed Quotes
OCUL Ocular Therapeutix
- 8.440
- -0.100-1.17%
Close Dec 27 16:00 ET
- 8.440
- 0.0000.00%
Post 16:20 ET
1.33BMarket Cap-7.09P/E (TTM)
8.530High8.270Low1.11MVolume8.530Open8.540Pre Close9.31MTurnover0.92%Turnover RatioLossP/E (Static)157.22MShares11.77552wk High3.77P/B1.01BFloat Cap3.76052wk Low--Dividend TTM120.14MShs Float44.190Historical High--Div YieldTTM3.04%Amplitude1.995Historical Low8.411Avg Price1Lot Size
Ocular Therapeutix Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -372.83%-36.56M | -23.55%-24.8M | -69.66%-33.89M | -17.84%-70.23M | -32.41%-22.45M | 41.29%-7.73M | -84.58%-20.08M | -7.38%-19.97M | 9.07%-59.6M | -11.91%-16.96M |
| Net income from continuing operations | -6,972.29%-36.49M | -111.67%-43.78M | -113.89%-64.85M | -13.65%-80.74M | -88.01%-29.22M | 97.87%-516K | -10.21%-20.68M | -141.73%-30.32M | -984.05%-71.04M | -303.69%-15.54M |
| Operating gains losses | 66.16%-7.08M | 367.64%3.03M | 404.45%33.1M | 34.96%-9M | 223.59%6.48M | -1,947.35%-20.91M | 59.21%-1.13M | 194.34%6.56M | 82.28%-13.84M | 66.97%-5.24M |
| Depreciation and amortization | 7.75%959K | 46.63%956K | 90.48%920K | 41.44%2.98M | 95.11%958K | 74.85%890K | 18.12%652K | -13.29%483K | -12.89%2.11M | -13.86%491K |
| Other non cash items | -70.03%621K | -54.59%569K | 60.26%1.97M | 25.82%6.11M | 25.55%1.55M | 69.14%2.07M | 3.98%1.25M | 3.54%1.23M | 4.86%4.85M | 4.12%1.24M |
| Change In working capital | -119.46%-1.21M | 168.34%3.13M | -420.28%-13.01M | -649.37%-7.41M | -206.93%-6.55M | 59.01%6.22M | -199.03%-4.58M | 50.53%-2.5M | 146.50%1.35M | -107.28%-2.14M |
| -Change in receivables | -100.08%-3K | 40.40%-3.69M | -282.59%-367K | -2,454.74%-4.85M | -70.06%-2.59M | 447.06%3.72M | -326.97%-6.19M | 109.70%201K | 97.86%-190K | 3.79%-1.52M |
| -Change in inventory | 367.92%142K | -56.45%27K | 7.88%-269K | 54.28%-331K | 88.81%-48K | -17.78%-53K | 143.66%62K | -170.37%-292K | -1,377.55%-724K | -1,432.14%-429K |
| -Change in prepaid assets | -2,515.24%-7.04M | 913.07%1.55M | 117.83%128K | -620.89%-3.77M | -312.96%-2.93M | -155.69%-269K | -82.39%153K | -986.42%-718K | 815.84%723K | 18.76%-710K |
| -Change in payables and accrued expense | 107.45%5.9M | 671.63%5.44M | -669.68%-12.34M | 32.55%1.36M | -172.39%-590K | -4.02%2.84M | -49.86%705K | 61.48%-1.6M | -81.44%1.02M | 47.11%815K |
| -Change in other current assets | -19.01%311K | -85.52%54K | -0.96%413K | 149.45%1.57M | --396K | --384K | --373K | 497.14%417K | -424.97%-3.18M | ---- |
| -Change in other current liabilities | -63.74%-447K | 63.58%-193K | -49.28%-515K | -166.43%-1.81M | ---665K | ---273K | ---530K | ---345K | 300.96%2.73M | ---- |
| -Change in other working capital | 39.69%-79K | -107.36%-62K | 63.13%-59K | -55.66%427K | -178.48%-124K | 22.02%-131K | 349.11%842K | -112.20%-160K | -3.70%963K | --158K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -372.83%-36.56M | -23.55%-24.8M | -69.66%-33.89M | -17.84%-70.23M | -32.41%-22.45M | 41.29%-7.73M | -84.58%-20.08M | -7.38%-19.97M | 9.07%-59.6M | -11.91%-16.96M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 65.64%-89K | 62.71%-742K | 92.45%-255K | -63.85%-6.09M | 78.65%-459K | 67.38%-259K | -302.02%-1.99M | -1,124.28%-3.38M | -211.14%-3.72M | -240.73%-2.15M |
| Net PPE purchase and sale | 65.64%-89K | 62.71%-742K | 92.45%-255K | -63.85%-6.09M | 78.65%-459K | 67.38%-259K | -302.02%-1.99M | -1,124.28%-3.38M | -211.14%-3.72M | -240.73%-2.15M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 65.64%-89K | 62.71%-742K | 92.45%-255K | -63.85%-6.09M | 78.65%-459K | 67.38%-259K | -302.02%-1.99M | -1,124.28%-3.38M | -211.14%-3.72M | -240.73%-2.15M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -91.96%4.18M | -77.23%2.2M | 411,724.36%321.22M | 11,580.06%169.83M | 23,517.90%108.17M | 13,786.36%51.94M | 1,856.39%9.65M | -39.53%78K | -49.00%1.45M | -31.33%458K |
| Net issuance payments of debt | --0 | --0 | --0 | --56.35M | --0 | --56.35M | --0 | --0 | --0 | --0 |
| Net common stock issuance | --0 | --0 | --316.35M | --117.26M | --107.73M | --708K | --8.82M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 6,638.71%4.18M | 167.48%2.2M | 6,143.59%4.87M | -3.58%1.4M | -3.71%441K | -83.42%62K | 66.53%821K | -39.53%78K | -59.28%1.45M | -31.33%458K |
| Net other financing activities | ---- | ---- | ---- | ---5.18M | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -91.96%4.18M | -77.23%2.2M | 411,724.36%321.22M | 11,580.06%169.83M | 23,517.90%108.17M | 13,786.36%51.94M | 1,856.39%9.65M | -39.53%78K | -49.00%1.45M | -31.33%458K |
| Net cash flow | ||||||||||
| Beginning cash position | 574.72%461.3M | 499.89%484.65M | 89.86%197.57M | -37.28%104.06M | -8.47%112.31M | -49.84%68.37M | -45.11%80.79M | -37.28%104.06M | -27.80%165.93M | -32.22%122.71M |
| Current changes in cash | -173.89%-32.47M | -87.99%-23.35M | 1,333.48%287.08M | 251.15%93.51M | 557.14%85.26M | 423.38%43.94M | -14.18%-12.42M | -24.15%-23.27M | 3.18%-61.86M | -23.37%-18.65M |
| End cash Position | 281.82%428.83M | 574.72%461.3M | 499.89%484.65M | 89.86%197.57M | 89.86%197.57M | -8.47%112.31M | -49.84%68.37M | -45.11%80.79M | -37.28%104.06M | -37.28%104.06M |
| Free cash flow | -358.62%-36.65M | -15.77%-25.54M | -46.21%-34.14M | -20.54%-76.32M | -19.91%-22.91M | 42.77%-7.99M | -94.05%-22.07M | -23.71%-23.35M | 5.13%-63.32M | -21.06%-19.11M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.